The receptor tyrosine kinase MET and its cognate ligand hepatocyte growth factor (HGF) have been implicated in diverse aspects of tumour pathobiology, including tumour growth, survival, neoangiogenesis, invasion, and dissemination (Gherardi et al, 2012). This evidence concerns the gene MET and neoplasm.